HEADER BIOSYNTHETIC PROTEIN 26-MAR-08 3CNY TITLE CRYSTAL STRUCTURE OF A PUTATIVE INOSITOL CATABOLISM PROTEIN IOLE TITLE 2 (IOLE, LP_3607) FROM LACTOBACILLUS PLANTARUM WCFS1 AT 1.85 A TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: INOSITOL CATABOLISM PROTEIN IOLE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LACTOBACILLUS PLANTARUM WCFS1; SOURCE 3 ORGANISM_TAXID: 220668; SOURCE 4 STRAIN: WCFS1 / NCIMB 8826; SOURCE 5 ATCC: BAA-793; SOURCE 6 GENE: NP_786806.1, IOLE, LP_3607; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDE5T KEYWDS XYLOSE ISOMERASE-LIKE TIM BARREL, STRUCTURAL GENOMICS, JOINT CENTER KEYWDS 2 FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, KEYWDS 3 BIOSYNTHETIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 01-FEB-23 3CNY 1 REMARK SEQADV REVDAT 5 24-JUL-19 3CNY 1 REMARK LINK REVDAT 4 25-OCT-17 3CNY 1 REMARK REVDAT 3 23-MAR-11 3CNY 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 3CNY 1 VERSN REVDAT 1 08-APR-08 3CNY 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE INOSITOL CATABOLISM PROTEIN JRNL TITL 2 IOLE (NP_786806.1) FROM LACTOBACILLUS PLANTARUM AT 1.85 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 57116 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.167 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2891 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3825 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.69 REMARK 3 BIN R VALUE (WORKING SET) : 0.2340 REMARK 3 BIN FREE R VALUE SET COUNT : 203 REMARK 3 BIN FREE R VALUE : 0.3010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4747 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 749 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.37 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.00000 REMARK 3 B22 (A**2) : -0.55000 REMARK 3 B33 (A**2) : -1.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.130 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.127 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.085 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.773 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4989 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3375 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6765 ; 1.398 ; 1.946 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8253 ; 0.952 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 629 ; 5.784 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 251 ;38.596 ;24.980 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 855 ;12.718 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;10.570 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 719 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5638 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 998 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1029 ; 0.208 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3707 ; 0.193 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2392 ; 0.182 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2461 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 639 ; 0.154 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 12 ; 0.123 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 31 ; 0.227 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 37 ; 0.174 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3297 ; 1.888 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1240 ; 0.696 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4874 ; 2.460 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2176 ; 4.319 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1875 ; 5.323 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 4 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 5 A 44 2 REMARK 3 1 B 5 B 44 2 REMARK 3 2 A 46 A 197 2 REMARK 3 2 B 46 B 197 2 REMARK 3 3 A 200 A 220 2 REMARK 3 3 B 200 B 220 2 REMARK 3 4 A 222 A 289 2 REMARK 3 4 B 222 B 289 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 1646 ; 0.080 ; 0.100 REMARK 3 MEDIUM POSITIONAL 1 A (A): 2049 ; 0.200 ; 0.250 REMARK 3 TIGHT THERMAL 1 A (A**2): 1646 ; 0.680 ; 1.000 REMARK 3 MEDIUM THERMAL 1 A (A**2): 2049 ; 1.340 ; 3.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF REMARK 3 THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR REMARK 3 THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. REMARK 3 3. EDO AND ACT FROM THE CRYSTALLIZATION/BUFFER WERE MODELED. REMARK 3 4. THE WATER 10 AND 11 POSITIONS ARE LOCATED IN THE ACTIVE REMARK 3 SITES AND ARE LIKELY REPLACED BY METALS IN AN ACTIVE ENZYME. REMARK 4 REMARK 4 3CNY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1000047004. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97908 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : FLAT COLLIMATING MIRROR, TOROID REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57200 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 29.273 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.74000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELX, AUTOSHARP, SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 0.2M (NH4)2H CITRATE, 20.0% REMARK 280 PEG 3350, NO BUFFER PH 5.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.61750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 123.45400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.77650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 123.45400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.61750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 25.77650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 GLY B 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 7 CE NZ REMARK 470 LYS A 58 CD CE NZ REMARK 470 LYS A 64 CD CE NZ REMARK 470 LYS A 86 CD CE NZ REMARK 470 GLU A 89 CD OE1 OE2 REMARK 470 LYS A 140 NZ REMARK 470 GLN A 295 CD OE1 NE2 REMARK 470 SER B 2 OG REMARK 470 SER B 3 OG REMARK 470 LYS B 4 CG CD CE NZ REMARK 470 LYS B 7 CD CE NZ REMARK 470 LYS B 58 CD CE NZ REMARK 470 LYS B 64 CD CE NZ REMARK 470 LYS B 93 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN B 167 -51.08 -120.62 REMARK 500 LEU B 297 -61.89 -109.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 383008 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3CNY A 1 300 UNP Q88S37 Q88S37_LACPL 1 300 DBREF 3CNY B 1 300 UNP Q88S37 Q88S37_LACPL 1 300 SEQADV 3CNY GLY A 0 UNP Q88S37 EXPRESSION TAG SEQADV 3CNY GLY B 0 UNP Q88S37 EXPRESSION TAG SEQRES 1 A 301 GLY MSE SER SER LYS ALA GLU LYS ASP ILE LYS TRP GLY SEQRES 2 A 301 ILE ALA PRO ILE GLY TRP ARG ASN ASP ASP ILE PRO SER SEQRES 3 A 301 ILE GLY LYS ASP ASN ASN LEU GLN GLN LEU LEU SER ASP SEQRES 4 A 301 ILE VAL VAL ALA GLY PHE GLN GLY THR GLU VAL GLY GLY SEQRES 5 A 301 PHE PHE PRO GLY PRO GLU LYS LEU ASN TYR GLU LEU LYS SEQRES 6 A 301 LEU ARG ASN LEU GLU ILE ALA GLY GLN TRP PHE SER SER SEQRES 7 A 301 TYR ILE ILE ARG ASP GLY ILE GLU LYS ALA SER GLU ALA SEQRES 8 A 301 PHE GLU LYS HIS CYS GLN TYR LEU LYS ALA ILE ASN ALA SEQRES 9 A 301 PRO VAL ALA VAL VAL SER GLU GLN THR TYR THR ILE GLN SEQRES 10 A 301 ARG SER ASP THR ALA ASN ILE PHE LYS ASP LYS PRO TYR SEQRES 11 A 301 PHE THR ASP LYS GLU TRP ASP GLU VAL CYS LYS GLY LEU SEQRES 12 A 301 ASN HIS TYR GLY GLU ILE ALA ALA LYS TYR GLY LEU LYS SEQRES 13 A 301 VAL ALA TYR HIS HIS HIS MSE GLY THR GLY ILE GLN THR SEQRES 14 A 301 LYS GLU GLU THR ASP ARG LEU MSE ALA ASN THR ASP PRO SEQRES 15 A 301 LYS LEU VAL GLY LEU LEU TYR ASP THR GLY HIS ILE ALA SEQRES 16 A 301 VAL SER ASP GLY ASP TYR MSE ALA LEU LEU ASN ALA HIS SEQRES 17 A 301 ILE ASP ARG VAL VAL HIS VAL HIS PHE LYS ASP VAL ARG SEQRES 18 A 301 ARG SER LYS GLU GLU GLU CYS ARG ALA LYS GLY LEU THR SEQRES 19 A 301 PHE GLN GLY SER PHE LEU ASN GLY MSE PHE THR VAL PRO SEQRES 20 A 301 GLY ASP GLY ASP LEU ASP PHE LYS PRO VAL TYR ASP LYS SEQRES 21 A 301 LEU ILE ALA ASN ASN TYR LYS GLY TRP ILE VAL VAL GLU SEQRES 22 A 301 ALA GLU GLN ASP PRO SER LYS ALA ASN PRO LEU GLU MSE SEQRES 23 A 301 ALA GLN ILE ALA HIS ARG TYR ILE LYS GLN HIS LEU ILE SEQRES 24 A 301 GLU ASN SEQRES 1 B 301 GLY MSE SER SER LYS ALA GLU LYS ASP ILE LYS TRP GLY SEQRES 2 B 301 ILE ALA PRO ILE GLY TRP ARG ASN ASP ASP ILE PRO SER SEQRES 3 B 301 ILE GLY LYS ASP ASN ASN LEU GLN GLN LEU LEU SER ASP SEQRES 4 B 301 ILE VAL VAL ALA GLY PHE GLN GLY THR GLU VAL GLY GLY SEQRES 5 B 301 PHE PHE PRO GLY PRO GLU LYS LEU ASN TYR GLU LEU LYS SEQRES 6 B 301 LEU ARG ASN LEU GLU ILE ALA GLY GLN TRP PHE SER SER SEQRES 7 B 301 TYR ILE ILE ARG ASP GLY ILE GLU LYS ALA SER GLU ALA SEQRES 8 B 301 PHE GLU LYS HIS CYS GLN TYR LEU LYS ALA ILE ASN ALA SEQRES 9 B 301 PRO VAL ALA VAL VAL SER GLU GLN THR TYR THR ILE GLN SEQRES 10 B 301 ARG SER ASP THR ALA ASN ILE PHE LYS ASP LYS PRO TYR SEQRES 11 B 301 PHE THR ASP LYS GLU TRP ASP GLU VAL CYS LYS GLY LEU SEQRES 12 B 301 ASN HIS TYR GLY GLU ILE ALA ALA LYS TYR GLY LEU LYS SEQRES 13 B 301 VAL ALA TYR HIS HIS HIS MSE GLY THR GLY ILE GLN THR SEQRES 14 B 301 LYS GLU GLU THR ASP ARG LEU MSE ALA ASN THR ASP PRO SEQRES 15 B 301 LYS LEU VAL GLY LEU LEU TYR ASP THR GLY HIS ILE ALA SEQRES 16 B 301 VAL SER ASP GLY ASP TYR MSE ALA LEU LEU ASN ALA HIS SEQRES 17 B 301 ILE ASP ARG VAL VAL HIS VAL HIS PHE LYS ASP VAL ARG SEQRES 18 B 301 ARG SER LYS GLU GLU GLU CYS ARG ALA LYS GLY LEU THR SEQRES 19 B 301 PHE GLN GLY SER PHE LEU ASN GLY MSE PHE THR VAL PRO SEQRES 20 B 301 GLY ASP GLY ASP LEU ASP PHE LYS PRO VAL TYR ASP LYS SEQRES 21 B 301 LEU ILE ALA ASN ASN TYR LYS GLY TRP ILE VAL VAL GLU SEQRES 22 B 301 ALA GLU GLN ASP PRO SER LYS ALA ASN PRO LEU GLU MSE SEQRES 23 B 301 ALA GLN ILE ALA HIS ARG TYR ILE LYS GLN HIS LEU ILE SEQRES 24 B 301 GLU ASN MODRES 3CNY MSE A 1 MET SELENOMETHIONINE MODRES 3CNY MSE A 162 MET SELENOMETHIONINE MODRES 3CNY MSE A 176 MET SELENOMETHIONINE MODRES 3CNY MSE A 201 MET SELENOMETHIONINE MODRES 3CNY MSE A 242 MET SELENOMETHIONINE MODRES 3CNY MSE A 285 MET SELENOMETHIONINE MODRES 3CNY MSE B 1 MET SELENOMETHIONINE MODRES 3CNY MSE B 162 MET SELENOMETHIONINE MODRES 3CNY MSE B 176 MET SELENOMETHIONINE MODRES 3CNY MSE B 201 MET SELENOMETHIONINE MODRES 3CNY MSE B 242 MET SELENOMETHIONINE MODRES 3CNY MSE B 285 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 162 8 HET MSE A 176 8 HET MSE A 201 8 HET MSE A 242 8 HET MSE A 285 8 HET MSE B 1 8 HET MSE B 162 8 HET MSE B 176 8 HET MSE B 201 8 HET MSE B 242 8 HET MSE B 285 8 HET EDO A 301 4 HET EDO A 302 4 HET ACT B 301 4 HET EDO B 302 4 HET EDO B 303 4 HET EDO B 304 4 HET EDO B 305 4 HETNAM MSE SELENOMETHIONINE HETNAM EDO 1,2-ETHANEDIOL HETNAM ACT ACETATE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 3 EDO 6(C2 H6 O2) FORMUL 5 ACT C2 H3 O2 1- FORMUL 10 HOH *749(H2 O) HELIX 1 1 SER A 2 ASP A 8 1 7 HELIX 2 2 PRO A 15 TRP A 18 5 4 HELIX 3 3 ASN A 31 GLY A 43 1 13 HELIX 4 4 GLY A 55 ARG A 66 1 12 HELIX 5 5 TYR A 78 ILE A 101 1 24 HELIX 6 6 THR A 131 TYR A 152 1 22 HELIX 7 7 THR A 168 ASN A 178 1 11 HELIX 8 8 THR A 190 GLY A 198 1 9 HELIX 9 9 TYR A 200 ILE A 208 1 9 HELIX 10 10 ARG A 220 GLY A 231 1 12 HELIX 11 11 THR A 233 ASN A 240 1 8 HELIX 12 12 PHE A 253 ASN A 263 1 11 HELIX 13 13 ASN A 281 LEU A 297 1 17 HELIX 14 14 SER B 2 LYS B 7 1 6 HELIX 15 15 PRO B 15 TRP B 18 5 4 HELIX 16 16 ASN B 31 GLY B 43 1 13 HELIX 17 17 GLY B 55 ARG B 66 1 12 HELIX 18 18 TYR B 78 GLY B 83 1 6 HELIX 19 19 GLY B 83 ILE B 101 1 19 HELIX 20 20 THR B 131 TYR B 152 1 22 HELIX 21 21 THR B 168 ASN B 178 1 11 HELIX 22 22 THR B 190 GLY B 198 1 9 HELIX 23 23 TYR B 200 ILE B 208 1 9 HELIX 24 24 ARG B 220 GLY B 231 1 12 HELIX 25 25 THR B 233 ASN B 240 1 8 HELIX 26 26 PHE B 253 ASN B 263 1 11 HELIX 27 27 ASN B 281 LEU B 297 1 17 SHEET 1 A 7 ILE A 9 ILE A 13 0 SHEET 2 A 7 GLY A 267 VAL A 271 1 O ILE A 269 N LYS A 10 SHEET 3 A 7 VAL A 211 PHE A 216 1 N VAL A 214 O VAL A 270 SHEET 4 A 7 GLY A 185 ASP A 189 1 N TYR A 188 O HIS A 215 SHEET 5 A 7 LYS A 155 HIS A 159 1 N TYR A 158 O LEU A 187 SHEET 6 A 7 VAL A 105 GLU A 110 1 N ALA A 106 O LYS A 155 SHEET 7 A 7 GLY A 72 SER A 77 1 N PHE A 75 O VAL A 107 SHEET 1 B 2 GLY A 46 THR A 47 0 SHEET 2 B 2 GLU A 69 ILE A 70 1 O GLU A 69 N THR A 47 SHEET 1 C 2 ASP A 218 VAL A 219 0 SHEET 2 C 2 PHE A 243 THR A 244 -1 O THR A 244 N ASP A 218 SHEET 1 D 9 ILE B 9 ILE B 13 0 SHEET 2 D 9 GLY B 46 GLU B 48 1 O GLY B 46 N ILE B 13 SHEET 3 D 9 GLU B 69 SER B 77 1 O ALA B 71 N THR B 47 SHEET 4 D 9 VAL B 105 GLU B 110 1 O VAL B 107 N PHE B 75 SHEET 5 D 9 LYS B 155 HIS B 159 1 O HIS B 159 N VAL B 108 SHEET 6 D 9 GLY B 185 ASP B 189 1 O GLY B 185 N TYR B 158 SHEET 7 D 9 VAL B 211 PHE B 216 1 O HIS B 215 N TYR B 188 SHEET 8 D 9 GLY B 267 VAL B 271 1 O VAL B 270 N VAL B 214 SHEET 9 D 9 ILE B 9 ILE B 13 1 N GLY B 12 O ILE B 269 SHEET 1 E 2 ASP B 218 VAL B 219 0 SHEET 2 E 2 PHE B 243 THR B 244 -1 O THR B 244 N ASP B 218 LINK C MSE A 1 N SER A 2 1555 1555 1.33 LINK C HIS A 161 N MSE A 162 1555 1555 1.32 LINK C MSE A 162 N GLY A 163 1555 1555 1.31 LINK C LEU A 175 N MSE A 176 1555 1555 1.33 LINK C MSE A 176 N ALA A 177 1555 1555 1.32 LINK C TYR A 200 N MSE A 201 1555 1555 1.34 LINK C MSE A 201 N ALA A 202 1555 1555 1.32 LINK C GLY A 241 N MSE A 242 1555 1555 1.35 LINK C MSE A 242 N PHE A 243 1555 1555 1.34 LINK C GLU A 284 N MSE A 285 1555 1555 1.34 LINK C MSE A 285 N ALA A 286 1555 1555 1.35 LINK C MSE B 1 N SER B 2 1555 1555 1.34 LINK C HIS B 161 N MSE B 162 1555 1555 1.33 LINK C MSE B 162 N GLY B 163 1555 1555 1.34 LINK C LEU B 175 N MSE B 176 1555 1555 1.32 LINK C MSE B 176 N ALA B 177 1555 1555 1.33 LINK C TYR B 200 N MSE B 201 1555 1555 1.33 LINK C MSE B 201 N ALA B 202 1555 1555 1.33 LINK C GLY B 241 N MSE B 242 1555 1555 1.32 LINK C MSE B 242 N PHE B 243 1555 1555 1.33 LINK C GLU B 284 N MSE B 285 1555 1555 1.33 LINK C MSE B 285 N ALA B 286 1555 1555 1.34 SITE 1 AC1 3 GLN B 73 HIS B 94 TYR B 97 SITE 1 AC2 5 GLY A 50 GLY A 51 PHE A 53 GLN A 73 SITE 2 AC2 5 TYR A 97 SITE 1 AC3 4 TRP B 11 GLY B 43 PHE B 44 HIS B 290 SITE 1 AC4 1 ARG B 291 SITE 1 AC5 2 PRO B 181 GLY B 185 SITE 1 AC6 3 ALA B 42 GLY B 43 GLU B 85 SITE 1 AC7 2 GLN A 73 TYR A 97 CRYST1 51.235 51.553 246.908 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019518 0.000000 0.000000 0.00000 SCALE2 0.000000 0.019398 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004050 0.00000 HETATM 1 N MSE A 1 14.334 26.140 11.453 1.00 48.66 N HETATM 2 CA MSE A 1 15.565 25.806 12.246 1.00 47.26 C HETATM 3 C MSE A 1 15.173 25.545 13.707 1.00 46.74 C HETATM 4 O MSE A 1 14.166 26.083 14.188 1.00 46.12 O HETATM 5 CB MSE A 1 16.603 26.938 12.134 1.00 47.16 C HETATM 6 CG MSE A 1 16.039 28.330 12.360 1.00 45.55 C HETATM 7 SE MSE A 1 17.433 29.721 12.396 0.75 42.48 SE HETATM 8 CE MSE A 1 18.045 29.706 10.498 1.00 38.14 C